Centurion Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Centurion Wealth Management's ABBV Position: Q3 2026 in Review
Centurion Wealth Management reduced its AbbVie (ABBV) stake by 4.6% in Q3 2026, selling an estimated $32.6K and leaving 2,638 shares worth $690K. The position accounts for 0.17% of the portfolio, ranked #120.
Centurion Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. The position peaked at $696K in Q2 2026. 1,321 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Centurion Wealth Management held 2,638 shares of AbbVie worth $690K as of Q3 2026.
- Centurion Wealth Management sold 127 AbbVie shares in Q3 2026, an estimated $32.6K.
- AbbVie made up 0.17% of Centurion Wealth Management's portfolio in Q3 2026, its #120 holding.
- Centurion Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
- Centurion Wealth Management's AbbVie position peaked at $696K in Q2 2026.
- 1,321 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Centurion Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.